Institutional Ownership Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX). We have compiled data on the 139 institutions that hold shares in the stock, with a total of 108 Million shares, which have been reported (via 13F filing form) to have a value of $107 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Broadwood Capital Inc
New York, NY |
May 14, 2025 Q1 2025 |
49,560,992
shares
|
$49.1 Million
1.86% of portfolio
|
Q1 2025
Added 18.95%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
9,559,466
shares
|
$9.46 Million
0.0% of portfolio
|
Q2 2024
Added 12.54%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
8,919,043
shares
|
$8.83 Million
0.0% of portfolio
|
Q1 2025
Added 3.31%
|
|
|
Defender Capital, Llc.
|
Apr 28, 2025 Q1 2025 |
6,310,873
shares
|
$6.25 Million
1.19% of portfolio
|
Q1 2025
Added 5.83%
|
|
|
Raffles Associates LP
New York, NY |
May 15, 2025 Q1 2025 |
5,642,088
shares
|
$5.59 Million
3.45% of portfolio
|
Q1 2025
Added 2.73%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
4,485,586
shares
|
$4.44 Million
0.0% of portfolio
|
Q1 2025
Added 21.54%
|
|
|
Comerica Bank
|
May 14, 2025 Q1 2025 |
3,000,000
shares
|
$2.97 Million
0.01% of portfolio
|
Q1 2025
Added 275.0%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
2,650,186
shares
|
$2.62 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.91%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
May 15, 2025 Q1 2025 |
2,511,374
shares
|
$2.49 Million
0.34% of portfolio
|
Q4 2024
Added 85.93%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
2,291,381
shares
|
$2.27 Million
0.0% of portfolio
|
Q1 2025
Added 0.36%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,539,586
shares
|
$1.52 Million
0.0% of portfolio
|
Q1 2025
Added 20.8%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
968,781
shares
|
$959,093
0.0% of portfolio
|
Q1 2025
Added 46.77%
|
|
|
Gsa Capital Partners LLP
London, X0 |
May 08, 2025 Q1 2025 |
936,892
shares
|
$927,523
0.04% of portfolio
|
Q1 2025
Added 129.16%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
605,044
shares
|
$598,993
0.0% of portfolio
|
Q1 2025
Reduced 36.07%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
May 15, 2025 Q1 2025 |
528,656
shares
|
$523,369
0.0% of portfolio
|
Q1 2025
Added 1578.91%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
515,445
shares
|
$510,290
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
515,445
shares
|
$510,290
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
503,193
shares
|
$498,161
0.0% of portfolio
|
Q1 2025
Added 20.9%
|
|
|
Red Crane Wealth Management, LLC
San Francisco, CA |
May 09, 2025 Q1 2025 |
495,996
shares
|
$491,036
0.21% of portfolio
|
Q1 2025
Added 45.78%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
480,423
shares
|
$475,618
0.0% of portfolio
|
Q1 2025
Added 59.32%
|
|
|
Squarepoint Ops LLC
New York, NY |
May 15, 2025 Q1 2025 |
357,772
shares
|
$354,194
0.0% of portfolio
|
Q1 2025
Added 288.88%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
350,103
shares
|
$346,601
0.0% of portfolio
|
Q1 2025
Reduced 9.08%
|
|
|
ETF Managers Group, LLC
Summit, NJ |
Apr 17, 2023 Q1 2023 |
318,596
shares
|
$315,410
0.02% of portfolio
|
Q1 2023
Reduced 10.0%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
263,917
shares
|
$261,277
0.0% of portfolio
|
Q1 2025
Added 19.48%
|
|
|
Cookson Peirce & CO Inc
|
May 13, 2025 Q1 2025 |
250,000
shares
|
$247,500
0.01% of portfolio
|
Q1 2025
New holding
|